Pediatric Trials Network Research Contributes to Three Recent Drug Label Changes
Data provided to the FDA by the research network has helped to provide a fuller picture for prescribing these medications to pediatric populations.
Novel Micra Pacemaker Found to Reduce Patient Risk
A pragmatic comparative effectiveness study comparing Micra leadless pacemakers to conventional transvenous pacemakers found that for patients who received the novel leadless pacemakers, complicati
DCRI Welcomes New Executive Director
A cardiologist and internationally recognized clinical research expert will become the Institute’s new leader.
PTN to Study Pediatric Dosing for Potential COVID-19 Drugs
Major Reform Needed to Enable a Learning Health System to Generate Evidence
A paper authored by the DCRI’s Adrian Hernandez, MD, MHS, and colleagues calls for major changes in the research ecosystem to enable pragmatic trials, especially those comparing different treatment
DCRI, Bayer Partner to Tackle Three Cardiovascular Conditions
New answers for patients with a range of heart conditions will soon be uncovered as part of a new collaboration between the DCRI and Bayer.
DCRI-Led Registry Launches, Invites Healthcare Workers Nationwide to Fight COVID-19 Together
DCRI Study Explores Potential Cardiometabolic Risks Associated with Prostate Cancer Treatment
A DCRI-led study called PRONOUNCE is comparing two types of androgen deprivation therapy (ADT) to determine whether one may lead to less cardio-metabolic risk for patients with atherosclerotic card
Oral Anticoagulation May Be Harmful to Patients with End-Stage Renal Disease
Contributors to Inaccurate Heart Rate Measurements in Wearable Devices
A study led by DCRI and Duke researchers was the first to comprehensively explore skin tone as a potential factor affecting accuracy of heart rate measurements from wearable devices.